NEA Management Company as of March 31, 2021
Portfolio Holdings for NEA Management Company
NEA Management Company holds 58 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Coursera (COUR) | 21.4 | $952M | 21M | 45.00 | |
| Desktop Metal Com Cl A | 9.5 | $423M | 28M | 14.90 | |
| Eargo | 7.3 | $326M | 6.5M | 49.95 | |
| Allakos (ALLK) | 5.6 | $249M | 2.2M | 114.78 | |
| Cloudflare Cl A Com (NET) | 4.4 | $194M | 2.8M | 70.26 | |
| Crispr Therapeutics Namen Akt (CRSP) | 4.3 | $194M | 1.6M | 121.85 | |
| Opendoor Technologies (OPEN) | 3.2 | $141M | 6.7M | 21.19 | |
| Oyster Point Pharma | 2.4 | $108M | 5.9M | 18.28 | |
| Rhythm Pharmaceuticals (RYTM) | 2.3 | $105M | 4.9M | 21.27 | |
| Metromile | 2.2 | $97M | 9.4M | 10.29 | |
| Nkarta (NKTX) | 2.1 | $96M | 2.9M | 32.90 | |
| Adaptimmune Therapeutics Adr (ADAP) | 2.0 | $91M | 17M | 5.31 | |
| Ardelyx (ARDX) | 2.0 | $90M | 14M | 6.62 | |
| Sprout Social Com Cl A (SPT) | 2.0 | $89M | 1.5M | 57.76 | |
| Black Diamond Therapeutics (BDTX) | 1.9 | $84M | 3.4M | 24.26 | |
| Mirum Pharmaceuticals (MIRM) | 1.9 | $83M | 4.2M | 19.82 | |
| Upstart Hldgs (UPST) | 1.7 | $74M | 573k | 128.86 | |
| Annexon (ANNX) | 1.6 | $70M | 2.5M | 27.84 | |
| Aurinia Pharmaceuticals (AUPH) | 1.5 | $67M | 5.2M | 12.99 | |
| Trillium Therapeutics Com New | 1.4 | $62M | 5.7M | 10.74 | |
| Akouos | 1.3 | $60M | 4.3M | 13.87 | |
| Savara (SVRA) | 1.1 | $50M | 24M | 2.08 | |
| Inozyme Pharma (INZY) | 1.1 | $48M | 2.4M | 19.80 | |
| Casper Sleep | 1.0 | $45M | 6.2M | 7.24 | |
| Affimed Therapeutics B V | 1.0 | $43M | 5.4M | 7.91 | |
| Verona Pharma Ads (VRNA) | 1.0 | $43M | 5.1M | 8.36 | |
| Galera Therapeutics (GRTX) | 0.9 | $39M | 4.4M | 8.82 | |
| Bloom Energy Corp Com Cl A (BE) | 0.8 | $36M | 1.3M | 27.05 | |
| Vistagen Therapeutics | 0.8 | $35M | 16M | 2.13 | |
| Imara | 0.8 | $34M | 4.0M | 8.44 | |
| Mei Pharma Com New | 0.7 | $29M | 8.5M | 3.43 | |
| Aveo Pharmaceuticals | 0.6 | $29M | 4.0M | 7.32 | |
| Tracon Pharmaceuticals | 0.6 | $29M | 347k | 82.30 | |
| Genocea Biosciences (GNCAQ) | 0.6 | $28M | 10M | 2.71 | |
| Glycomimetics (GLYC) | 0.6 | $27M | 9.1M | 3.01 | |
| Marker Therapeutics Ord | 0.5 | $24M | 11M | 2.24 | |
| Phasebio Pharmaceuticals | 0.5 | $23M | 6.6M | 3.46 | |
| Geron Corporation (GERN) | 0.5 | $21M | 14M | 1.58 | |
| Cti Biopharma Corp Com New | 0.5 | $21M | 7.1M | 2.91 | |
| Champions Oncology Com New (CSBR) | 0.4 | $19M | 1.7M | 11.30 | |
| Metacrine Ord | 0.4 | $19M | 3.1M | 6.20 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $18M | 992k | 17.90 | |
| Satsuma Pharmaceuticals Ord | 0.4 | $18M | 3.0M | 5.91 | |
| Trevi Therapeutics (TRVI) | 0.4 | $16M | 5.9M | 2.71 | |
| Inventiva Sa Ads (IVA) | 0.3 | $15M | 1.0M | 14.70 | |
| Synlogic | 0.3 | $15M | 4.2M | 3.58 | |
| Obseva Sa | 0.3 | $15M | 4.6M | 3.25 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.3 | $14M | 2.4M | 5.87 | |
| Strongbridge Biopharma Shs Usd | 0.3 | $11M | 4.1M | 2.76 | |
| Regulus Therapeutics Com New | 0.2 | $10M | 6.5M | 1.56 | |
| Trevena | 0.2 | $6.8M | 3.8M | 1.79 | |
| Liquidia Technologies (LQDA) | 0.2 | $6.7M | 2.5M | 2.69 | |
| Lumos Pharma (LUMO) | 0.1 | $6.2M | 527k | 11.70 | |
| Erytech Pharma Sa Adr | 0.1 | $4.4M | 625k | 7.04 | |
| Millendo Therapeutics | 0.0 | $2.1M | 1.8M | 1.20 | |
| Akari Therapeutics Adr | 0.0 | $1.2M | 452k | 2.64 | |
| DZS (DZSI) | 0.0 | $598k | 39k | 15.54 | |
| Viracta Therapeutics (VIRX) | 0.0 | $343k | 37k | 9.25 |
